“Improving BNT162b2 MRNA Vaccine Tolerability Without Efficacy Loss by Pidotimod Supplementation: Pidotimod in SARS-CoV-2 Vaccination”. Mediterranean Journal of Hematology and Infectious Diseases 14, no. 1 (February 27, 2022): e2022023. Accessed May 26, 2026. https://www.mjhid.org/mjhid/article/view/4820.